Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression
Year: 2010
Type: article
Source: Journal of Affective Disorders
Institutions: University Hospitals Cleveland Medical Center, Case Western Reserve University, SK Life Science (United States), Bristol-Myers Squibb (United States), GlaxoSmithKline (United States), Weill Cornell Medicine, AstraZeneca (United States), Psychiatrische Universitätsklinik Zürich, Merck & Co., Inc., Rahway, NJ, USA (United States), The University of Texas at San Antonio Health Science Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2077922850
